FDA Approved: METRONIDAZOLE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for Metronidazole from Chartwell RX, LLC (ANDA number 076522).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amebiasis
• Amebic Liver Abscess
• Bacterial Vaginosis
• Giardiasis
• Intra-abdominal Infection
• Pelvic Inflammatory Disease
• Rosacea
• Trichomoniasis

Drugs mentioned

• METRONIDAZOLE (Metronidazole)

Snippet

SUPPL AP for METRONIDAZOLE (METRONIDAZOLE)